Related Experiment Video
Updated: Mar 15, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated
Jun Xiao1, Huan-Yi Lin2, Yuan-Yuan Zhu3
1Department of Urology, Anhui Provincial Hospital, Anhui Medical University, Hefei.
Objective:
To assess whether microRNA-126 (miR-126) targets phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2) and to determine the potential roles of miR-126 in regulating proliferation and invasion via the PIK3R2-mediated phosphatidylinositol 3 kinase (PI3K)-protein kinase B (Akt) signaling pathway in the human bladder BLS cell line.
Materials And Methods:
A recombinant lentivirus (Lv) vector expressing miR-216 (Lv-miR-126) was successfully constructed, and Lv-miR-126 and Lv vector were transfected into the BLS cell line. A direct regulatory relationship between miR-126 and the PIK3R2 gene was demonstrated by luciferase reporter assays. To determine whether PIK3R2 directly participates in the miR-126-induced effects in BLS cells, anti-miR-126 and a PIK3R2 small interfering RNA (siRNA) were transfected into the BLS cells. Quantitative real-time polymerase chain reaction was used to measure miR-126 and PIK3R2 expressions. 5-Ethynyl-2'-deoxyuridine and colony formation assays to assess cell proliferation, flow cytometry for cell apoptosis and cell cycle analysis, Transwell assays for cell migration and invasion, and Western blots for PIK3R2, PI3K, phosphorylated PI3K (p-PI3K), Akt, and phosphorylated Akt (p-Akt) protein expressions were performed.
Results:
Lv-miR-126 significantly enhanced the relative expression of miR-126 in the BLS cells after infection (P<0.0001). MiR-126 overexpression inhibited the proliferation, cloning, migration, and invasion of BLS cells, promoted cell apoptosis, and induced S phase arrest (all P<0.05). PIK3R2, p-PI3K, and p-Akt protein expressions were significantly decreased in the BLS cells infected with Lv-miR-126. Luciferase assays showed that miR-126 significantly inhibited the PIK3R2 3' untranslated region (3'UTR) luciferase reporter activity (P<0.05). The anti-miR-126 + PIK3R2 siRNA group had significantly decreased PIK3R2, p-PI3K, and p-Akt expressions compared with those of anti-miR-126 alone, as well as significantly decreased proliferation, invasion, and metastasis and increased apoptosis compared with the anti-miR-126 group (all P<0.05). Additionally, proliferation, invasion, and metastasis were significantly increased, and cell apoptosis was decreased compared with the PIK3R2 siRNA group (all P<0.05).
Conclusion:
Overexpression of miR-126 negatively regulated the target gene PIK3R2 and further inhibited the PI3K/Akt signaling pathway, thereby inhibiting proliferation, migration, and invasion and promoting apoptosis in BLS cells.
Insights
MicroRNA-126 (miR-126) inhibits bladder cancer cell growth and spread by targeting PIK3R2 and the PI3K/Akt pathway. This study confirms miR-126
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- MicroRNAs (miRNAs) play crucial roles in regulating gene expression.
- Dysregulation of miRNAs is implicated in various cancers, including bladder cancer.
- The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway is frequently activated in cancer and promotes cell proliferation and survival.
Purpose of the Study:
- To investigate whether microRNA-126 (miR-126) targets phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2).
- To determine the role of miR-126 in regulating bladder cancer cell proliferation and invasion through the PIK3R2-mediated PI3K/Akt signaling pathway.
Main Methods:
- Construction and transfection of a recombinant lentivirus vector expressing miR-126 (Lv-miR-126) into human bladder BLS cells.
- Luciferase reporter assays to confirm the direct targeting of PIK3R2 by miR-126.
- Quantitative real-time PCR, cell proliferation assays (EdU, colony formation), apoptosis and cell cycle analysis (flow cytometry), Transwell assays for migration and invasion, and Western blotting to assess protein expression.
Main Results:
- Overexpression of miR-126 significantly inhibited BLS cell proliferation, migration, and invasion, while promoting apoptosis and inducing S phase arrest.
- miR-126 overexpression led to decreased expression of PIK3R2, p-PI3K, and p-Akt.
- Luciferase assays confirmed that miR-126 directly targets the 3' untranslated region of PIK3R2.
- Inhibition of PIK3R2 using siRNA in the presence of anti-miR-126 further reduced PIK3R2, p-PI3K, and p-Akt expression, and suppressed proliferation and invasion.
Conclusions:
- miR-126 acts as a tumor suppressor in bladder cancer cells.
- miR-126 negatively regulates PIK3R2, thereby inhibiting the PI3K/Akt signaling pathway.
- These findings highlight the therapeutic potential of miR-126 in bladder cancer treatment.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation